<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>NextConsensus registered forecasts</title>
    <link>https://nextconsensus.com/forecast/</link>
    <description>Each forecast when it is registered, and each when it is adjudicated. The finding is on each forecast's page.</description>
    <lastBuildDate>Tue, 06 Oct 2026 00:00:00 GMT</lastBuildDate>
    <language>en</language>
  <item>
    <title>FF-023 registered: Bezuclastinib · GIST approval</title>
    <link>https://nextconsensus.com/forecast/ff-023/</link>
    <guid isPermaLink="false">registration-ff-023</guid>
    <pubDate>Tue, 06 Oct 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-10-06, before the outcome. Event by 2026-11-30. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-024 registered: D-PLEX100 · colorectal surgical site infection approval</title>
    <link>https://nextconsensus.com/forecast/ff-024/</link>
    <guid isPermaLink="false">registration-ff-024</guid>
    <pubDate>Tue, 06 Oct 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-10-06, before the outcome. Event by 2026-11-28. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-025 registered: Neladalkib · ALK-positive NSCLC approval</title>
    <link>https://nextconsensus.com/forecast/ff-025/</link>
    <guid isPermaLink="false">registration-ff-025</guid>
    <pubDate>Tue, 06 Oct 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-10-06, before the outcome. Event by 2026-11-27. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-026 registered: Povetacicept · IgA nephropathy approval</title>
    <link>https://nextconsensus.com/forecast/ff-026/</link>
    <guid isPermaLink="false">registration-ff-026</guid>
    <pubDate>Tue, 06 Oct 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-10-06, before the outcome. Event by 2026-11-30. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-027 registered: Venglustat · type 3 Gaucher disease approval</title>
    <link>https://nextconsensus.com/forecast/ff-027/</link>
    <guid isPermaLink="false">registration-ff-027</guid>
    <pubDate>Tue, 06 Oct 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-10-06, before the outcome. Event by 2026-11-25. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-028 registered: Obicetrapib · hypercholesterolaemia guidance publication</title>
    <link>https://nextconsensus.com/forecast/ff-028/</link>
    <guid isPermaLink="false">registration-ff-028</guid>
    <pubDate>Tue, 06 Oct 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-10-06, before the outcome. Event by 2026-11-25. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-029 registered: Polihexanide · acanthamoeba keratitis guidance publication</title>
    <link>https://nextconsensus.com/forecast/ff-029/</link>
    <guid isPermaLink="false">registration-ff-029</guid>
    <pubDate>Tue, 06 Oct 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-10-06, before the outcome. Event by 2026-11-25. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-005 registered: Aficamten · MAPLE-HCM supplement approval</title>
    <link>https://nextconsensus.com/forecast/ff-005/</link>
    <guid isPermaLink="false">registration-ff-005</guid>
    <pubDate>Sat, 26 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-26, before the outcome. Event by 2026-11-14. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-006 registered: BBP-418 · muscular dystrophy approval</title>
    <link>https://nextconsensus.com/forecast/ff-006/</link>
    <guid isPermaLink="false">registration-ff-006</guid>
    <pubDate>Sat, 26 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-26, before the outcome. Event by 2026-11-27. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-007 registered: Bepirovirsen · hepatitis B approval</title>
    <link>https://nextconsensus.com/forecast/ff-007/</link>
    <guid isPermaLink="false">registration-ff-007</guid>
    <pubDate>Sat, 26 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-26, before the outcome. Event by 2026-10-26. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-008 registered: Deramiocel · Duchenne approval</title>
    <link>https://nextconsensus.com/forecast/ff-008/</link>
    <guid isPermaLink="false">registration-ff-008</guid>
    <pubDate>Sat, 26 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-26, before the outcome. Event by 2026-11-22. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-009 registered: IGALMI · at-home supplement approval</title>
    <link>https://nextconsensus.com/forecast/ff-009/</link>
    <guid isPermaLink="false">registration-ff-009</guid>
    <pubDate>Sat, 26 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-26, before the outcome. Event by 2026-11-14. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-010 registered: INO-3107 · papillomatosis approval</title>
    <link>https://nextconsensus.com/forecast/ff-010/</link>
    <guid isPermaLink="false">registration-ff-010</guid>
    <pubDate>Sat, 26 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-26, before the outcome. Event by 2026-10-30. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-011 registered: Ivonescimab · post-TKI NSCLC approval</title>
    <link>https://nextconsensus.com/forecast/ff-011/</link>
    <guid isPermaLink="false">registration-ff-011</guid>
    <pubDate>Sat, 26 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-26, before the outcome. Event by 2026-11-14. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-012 registered: Mitapivat · sickle cell supplement approval</title>
    <link>https://nextconsensus.com/forecast/ff-012/</link>
    <guid isPermaLink="false">registration-ff-012</guid>
    <pubDate>Sat, 26 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-26, before the outcome. Event by 2026-11-01. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-013 registered: Molgramostim · aPAP approval</title>
    <link>https://nextconsensus.com/forecast/ff-013/</link>
    <guid isPermaLink="false">registration-ff-013</guid>
    <pubDate>Sat, 26 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-26, before the outcome. Event by 2026-11-22. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-014 registered: Beremagene geperpavec · guidance publication</title>
    <link>https://nextconsensus.com/forecast/ff-014/</link>
    <guid isPermaLink="false">registration-ff-014</guid>
    <pubDate>Sat, 26 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-26, before the outcome. Event by 2026-11-18. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-015 registered: Efgartigimod · CIDP guidance publication</title>
    <link>https://nextconsensus.com/forecast/ff-015/</link>
    <guid isPermaLink="false">registration-ff-015</guid>
    <pubDate>Sat, 26 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-26, before the outcome. Event by 2026-11-18. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-016 registered: Epcoritamab combination · guidance publication</title>
    <link>https://nextconsensus.com/forecast/ff-016/</link>
    <guid isPermaLink="false">registration-ff-016</guid>
    <pubDate>Sat, 26 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-26, before the outcome. Event by 2026-10-28. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-017 registered: Inavolisib combination · guidance publication</title>
    <link>https://nextconsensus.com/forecast/ff-017/</link>
    <guid isPermaLink="false">registration-ff-017</guid>
    <pubDate>Sat, 26 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-26, before the outcome. Event by 2026-11-03. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-018 registered: Larotrectinib · guidance publication</title>
    <link>https://nextconsensus.com/forecast/ff-018/</link>
    <guid isPermaLink="false">registration-ff-018</guid>
    <pubDate>Sat, 26 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-26, before the outcome. Event by 2026-11-18. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-019 registered: Nivolumab + ipilimumab · guidance publication</title>
    <link>https://nextconsensus.com/forecast/ff-019/</link>
    <guid isPermaLink="false">registration-ff-019</guid>
    <pubDate>Sat, 26 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-26, before the outcome. Event by 2026-11-11. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-020 registered: Orforglipron · guidance publication</title>
    <link>https://nextconsensus.com/forecast/ff-020/</link>
    <guid isPermaLink="false">registration-ff-020</guid>
    <pubDate>Sat, 26 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-26, before the outcome. Event by 2026-11-18. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-021 registered: Pembrolizumab combination · guidance publication</title>
    <link>https://nextconsensus.com/forecast/ff-021/</link>
    <guid isPermaLink="false">registration-ff-021</guid>
    <pubDate>Sat, 26 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-26, before the outcome. Event by 2026-11-18. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-022 registered: Zuranolone · guidance publication</title>
    <link>https://nextconsensus.com/forecast/ff-022/</link>
    <guid isPermaLink="false">registration-ff-022</guid>
    <pubDate>Sat, 26 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-26, before the outcome. Event by 2026-11-12. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-002 registered: Sunvozertinib · first-line approval</title>
    <link>https://nextconsensus.com/forecast/ff-002/</link>
    <guid isPermaLink="false">registration-ff-002</guid>
    <pubDate>Tue, 22 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-22, before the outcome. Event by 2027-07-31. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-003 registered: Sunvozertinib · first-line approval by March</title>
    <link>https://nextconsensus.com/forecast/ff-003/</link>
    <guid isPermaLink="false">registration-ff-003</guid>
    <pubDate>Tue, 22 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-22, before the outcome. Event by 2027-03-31. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-004 registered: Sunvozertinib · FDA approval before NCCN listing</title>
    <link>https://nextconsensus.com/forecast/ff-004/</link>
    <guid isPermaLink="false">registration-ff-004</guid>
    <pubDate>Tue, 22 Sep 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-09-22, before the outcome. Event by 2027-07-31. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  <item>
    <title>FF-001 registered: Sunvozertinib · first-line guideline listing</title>
    <link>https://nextconsensus.com/forecast/ff-001/</link>
    <guid isPermaLink="false">registration-ff-001</guid>
    <pubDate>Mon, 17 Aug 2026 00:00:00 GMT</pubDate>
    <description>Registered on 2026-08-17, before the outcome. Event by 2027-07-31. The forecast's page gives the probability, the baselines it has to beat, and the rule that settles it.</description>
  </item>
  </channel>
</rss>
